Stock Buybacks (Quarterly) Chart

View Stock Buybacks (Quarterly) for BLFS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Stock Buybacks (Quarterly) Chart
Start Trial

Historical Stock Buybacks (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2026 -0.003M
March 31, 2026 -0.19M
December 31, 2025 0.00
September 30, 2025 0.00
June 30, 2025 -0.018M
March 31, 2025 0.00
December 31, 2024 -0.065M
September 30, 2024 -0.046M
June 30, 2024 -0.091M
March 31, 2024 0.00
December 31, 2023 -10.38M
September 30, 2023 -0.064M
June 30, 2023 -0.181M
March 31, 2023 -0.125M
December 31, 2022 -0.015M
September 30, 2022 0.124M
June 30, 2022 -0.094M
March 31, 2022 -0.207M
December 31, 2021 -0.401M
September 30, 2021 -0.264M
June 30, 2021 -0.365M
March 31, 2021 -0.243M
December 31, 2020 -0.313M
September 30, 2020 -80.60M
June 30, 2020 -20.22M
Date Value
March 31, 2020 -0.499M
December 31, 2019 -0.405M
September 30, 2019 -0.75M
June 30, 2019 -0.416M
March 31, 2019 -0.184M
December 31, 2018 2.012M
September 30, 2018 -22.78M
June 30, 2018 -7.706M
March 31, 2018 -0.1296M
December 31, 2017 -3.194M
September 30, 2017 -0.4605M
June 30, 2017 -0.1812M
March 31, 2017 -0.0906M
December 31, 2016 0.025M
September 30, 2016 -0.0403M
June 30, 2016 -0.1193M
March 31, 2016 -0.0322M
December 31, 2015 -0.2688M
September 30, 2015 -0.02M
June 30, 2015 -0.055M
March 31, 2015 -0.0249M
December 31, 2014 -0.003M
September 30, 2014 0.00
June 30, 2014 -0.0806M
March 31, 2014 -13.60M

Stock Buyback Definition

Stock buybacks are when companies buy back their own stock, removing it from the marketplace. Stock buybacks increase the value of the remaining shares because there is now less common stock outstanding and company earnings are split among fewer shares.

Read full definition.

Stock Buybacks (Quarterly) Range, Past 5 Years

View Stock Buybacks (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Stock Buybacks (Quarterly) Benchmarks

View Stock Buybacks (Quarterly) Benchmarks
Start Trial
Repligen Corp. -0.094M
Agilent Technologies, Inc. 44.00M
Danaher Corp. 885.00M
Thermo Fisher Scientific, Inc. 1.00B
West Pharmaceutical Services, Inc. 147.90M